Seraxis

Germantown, United States · Founded 2013 · $47.0M raised

Founded
2013
Business Model
B2B
Total Funding
$47.0M
Last Round
$40.0M Series CJul 2025
Rounds
4

About

Seraxis develops pancreatic islet replacement therapies intended to treat insulin-requiring and type 1 diabetes. Its clinical candidate SR-02 uses replacement islets, while the company has also reported pancreatic organoids derived from its novel pancreas-derived stem cells and synthetic replacement endocrine clusters. The program has progressed through preclinical studies, GMP quality-system work, and FDA IND allowance for a clinical study of SR-02.

Summary

Seraxis is a Biotech company based in Germantown, United States, founded in 2013. It has raised $47.0M in total across 4 rounds, most recently a $40.0M Series C round in Jul 2025. Investors include Polaris Partners, Eli Lilly and Frazier Healthcare.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJul 2025
$40.0M

Sign up to see all 4 rounds

Seed through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Seraxis on Indexed.vc
<a href="https://indexed.vc/companies/seraxis"><img src="https://indexed.vc/api/badge/company/seraxis" alt="Seraxis on Indexed.vc" width="260" height="76" /></a>